Lower risk Drug recall · FDA · Published November 17, 2021

Sandoz Enoxaparin 40mg Syringes Risk from Temperature Abuse During Shipping

Sandoz recalls 40mg enoxaparin syringes due to temperature issues during shipping that could affect safety. Learn if your product is affected and what to do.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0286-2022Drug Sandoz ›

Lower-risk recall

Temperature Abuse; temperature excursion during shipping

Take action

Contact the company

Recalling firmSandoz Inc100 College Rd W · Princeton, NJ 08540-6604

✎ GovInfoNow plain-language explainer

Sandoz is recalling enoxaparin sodium injection syringes because they may have been exposed to incorrect temperatures during shipping. This could lead to the medication being unsafe for use. Read more at govinfonow.com/recall/35533-sandoz-enoxaparin-40mg-syringes-risk-from-temperature-abuse-during-shipping.

Source Summary by GovInfoNow · govinfonow.com/recall/35533-sandoz-enoxaparin-40mg-syringes-risk-from-temperature-abuse-during-shipping · Updated August 18, 2026 · FDA enforcement record: FDA #D-0286-2022

Cite this page

“Sandoz Enoxaparin 40mg Syringes Risk from Temperature Abuse During Shipping.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35533-sandoz-enoxaparin-40mg-syringes-risk-from-temperature-abuse-during-shipping. Based on FDA recall #D-0286-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0286-2022%22&limit=1).

The FDA announced on 2021-11-17 that Sandoz Inc is recalling Enoxaparin Sodium Injection, USP due to temperature abuse during shipping. The agency classified the recall as Class I.

How to tell if you have it

Brand: Sandoz
Product: Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL, Single-Dose Syringes with Automatic Safety Device, For Subcutaneous Injection
NDC: 00781-3246-02 (Syringes), 00781-3246-64 (Carton)
Lot #: SAB06761A
Expiration: 04/2023
Quantity: 45,036 cartons
Distribution: Nationwide in the US

The hazard

The recall addresses temperature excursion during shipping that may compromise the product. The FDA classified this as a Class I recall.

Context

GovInfoNow's records show Sandoz Inc has 29 other recalls on record since 2013-10-09. Recent Sandoz recalls include Focalin XR 5mg Capsules (2026-06-01), Cyclophosphamide Injection (2025-09-05), and Ciprofloxacin Otic Suspension (2025-08-13). Other recent recalls of similar products include UDENYCA Injection (2026-01-16), Zoladex Implants (2026-08-31), and Gemcitabine Injection (2026-06-10).

How to tell if you have this one

Check for the product name 'Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL, Single-Dose Syringes with Automatic Safety Device'. Look for the lot number SAB06761A or the expiration date of 04/2023.

Brand
Sandoz
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Details
Look for the lot number SAB06761A or expiration date 04/2023 on the syringe packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide in the US” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 21 days after the firm started it.

Nov 17, 2021Firm started the recall
Dec 8, 2021Published in FDA’s Enforcement Report
Dec 16, 2021FDA classified it Class I

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Sandoz recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/35533-sandoz-enoxaparin-40mg-syringes-risk-from-temperature-abuse-during-shipping">Sandoz Enoxaparin 40mg Syringes Risk from Temperature Abuse During Shipping (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0286-2022 (November 17, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0286-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.